Jeffrey Meckler
Chief Executive Officer bei INDAPTUS THERAPEUTICS, INC.
Vermögen: 743 233 $ am 31.03.2024
Profil
Jeffrey A.
Meckler is currently the Chief Executive Officer & Director at Indaptus Therapeutics, Inc. He is also a Director at Children of Bellevue, Inc. and an Independent Director at Travere Therapeutics, Inc. In the past, Mr. Meckler served as the Chief Executive Officer & Director at Cypress Bioscience, Inc. from 2011 to 2012.
He was also the Chief Executive Officer & Director at Cocrystal Pharma, Inc. from 2014 to 2016 and the Chief Executive Officer at Trieber Therapeutics, Inc. in 2017.
Additionally, he held positions such as President, CEO, Secretary & Director at Intec Parent, Inc. (United States), Vice Chairman at Intec Pharma Ltd.
in 2017, and Independent Director at QLT, Inc. from 2012 to 2016.
He was a Director at Alveolus, Inc. from 2007 to 2009 and a Managing Director at Andra Group, Inc. He also served as a Director at Kyalin Biosciences, Inc. from 2011 to 2012 and Clearfarma USA from 2010 to 2012.
Mr. Meckler obtained his graduate degree from Fordham University School of Law.
He also holds undergraduate and graduate degrees from the Tepper School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.05.2023 | 74 500 ( 0,10% ) | 574 395 $ | 31.03.2024 | |
| 22.01.2024 | 75 374 ( 0,88% ) | 168 838 $ | 31.03.2024 |
Aktive Positionen von Jeffrey Meckler
| Unternehmen | Position | Beginn |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Director/Board Member | 18.05.2016 |
| INDAPTUS THERAPEUTICS, INC. | Chief Executive Officer | 03.08.2021 |
Children of Bellevue, Inc.
 Children of Bellevue, Inc. Miscellaneous Commercial ServicesCommercial Services Children of Bellevue, Inc. is a non-profit organization that was founded in 1949 to improve the health and well-being of children at NYC Health + Hospitals/Bellevue. The non-profit company is based in New York, NY. The organization advocates for pediatric patients and their families and aims to alleviate the pain, loneliness, and fear that can accompany childhood hospitalization. The company also seeks to enhance early development and school-readiness in children at-risk of falling behind due to family poverty. All of their programs are made possible solely through philanthropic donations. | Director/Board Member | 01.01.2001 |
Ehemalige bekannte Positionen von Jeffrey Meckler
| Unternehmen | Position | Ende |
|---|---|---|
Trieber Therapeutics, Inc.
 Trieber Therapeutics, Inc. BiotechnologyHealth Technology Trieber Therapeutics, Inc. is an American biotechnology company that focuses on research and development. The private company is based in Wilmington. | Chief Executive Officer | 01.07.2017 |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Chief Executive Officer | 24.10.2014 |
| COCRYSTAL PHARMA, INC. | Chief Executive Officer | 22.07.2016 |
| Clearfarma USA | Director/Board Member | 01.11.2012 |
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Chief Executive Officer | 01.09.2012 |
Ausbildung von Jeffrey Meckler
| Fordham University School of Law | Graduate Degree |
| Tepper School of Business | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| COCRYSTAL PHARMA, INC. | Health Technology |
| INDAPTUS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Health Technology |
Alveolus, Inc.
 Alveolus, Inc. Medical SpecialtiesHealth Technology Alveolus, Inc. used to develop non-vascular interventional stent technology. The company was founded by Eric K. Mangiardi and Gerard A. Silvestri in 2001 and is headquartered in Charlotte, NC. | Health Technology |
Children of Bellevue, Inc.
Children of Bellevue, Inc. Miscellaneous Commercial ServicesCommercial Services Children of Bellevue, Inc. is a non-profit organization that was founded in 1949 to improve the health and well-being of children at NYC Health + Hospitals/Bellevue. The non-profit company is based in New York, NY. The organization advocates for pediatric patients and their families and aims to alleviate the pain, loneliness, and fear that can accompany childhood hospitalization. The company also seeks to enhance early development and school-readiness in children at-risk of falling behind due to family poverty. All of their programs are made possible solely through philanthropic donations. | Commercial Services |
| Andra Group, Inc. | |
Intec Pharma Ltd.
 Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel. | Health Technology |
Kyalin Biosciences, Inc.
 Kyalin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kyalin Biosciences, Inc. manufactures biopharmaceutical products. The firm develops an intranasal delivery form of carbetocin, which is a synthetic version of the natural occurring peptide hormone, oxytocin, for the treatment of core deficits that characterize the autistic spectrum disorders. The company was founded by Srinivas G. Rao and is headquartered in San Diego, CA. | Health Technology |
| Clearfarma USA | |
Trieber Therapeutics, Inc.
Trieber Therapeutics, Inc. BiotechnologyHealth Technology Trieber Therapeutics, Inc. is an American biotechnology company that focuses on research and development. The private company is based in Wilmington. | Health Technology |
| Intec Parent, Inc. (United States) |
